Pulmonary Disease Doctors in Des Moines, IA Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Dr. Randall R Hanson, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1215 Pleasant St, Ste 200, Des Moines, IA 50309 Phone: 515-241-6472    Fax: 515-241-3456

Dr. Donald L Burrows, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1601 Nw 114th St, Suite 347, Des Moines, IA 50325 Phone: 515-224-1777    Fax: 515-222-0226

Dr. Michael C Witte, DO Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 411 Laurel St Ste A120, Des Moines, IA 50314 Phone: 515-643-7900    Fax: 515-643-7901

Eric Asbe, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste A120, Des Moines, IA 50314 Phone: 515-643-7900    Fax: 515-643-7901

Shrey Vazirsultan Velani, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste A120, Des Moines, IA 50314 Phone: 515-643-7900    Fax: 515-643-7901

Bradley E Wilcox, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste A120, Des Moines, IA 50314 Phone: 515-643-7900    Fax: 515-643-7901

Donald Ray Shumate, D.O. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3200 Grand Ave, Des Moines, IA 50312 Phone: 515-271-1725    Fax: 515-271-1575

News Archive

CSL pays heed to FDA observations on faulty manufacturing processes

Australia's biggest pharmaceutical company CSL has taken steps to address most manufacturing flaws highlighted by the US Food and Drug Administration (FDA) and promised that the remaining concerns are being resolved.

G42 and Oxford Nanopore co-develop population-scale technology to detect SARS-CoV-2

Group 42 (G42), a leading AI and Cloud Computing company based in the United Arab Emirates, and Oxford Nanopore Technologies, an advanced sequencing technology company based in the United Kingdom, announced today they have developed an unprecedented population-scale technology that rapidly and accurately detects SARS-CoV-2, the virus that causes COVID-19.

Researchers develop Bergen Work Addiction Scale

Researchers from Norway and the United Kingdom have developed a new instrument to measure work addiction: The Bergen Work Addiction Scale. The new instrument is based on core elements of addiction that are recognised as diagnostic criteria for several addictions.

Roundup: Ill. to scrutinize Medicaid eligibility; 20% of Fla. nursing homes on 'watch' list; Conn.'s 'inadequate' mental health care system

Fort Pierce resident Cathi Odom recently learned that her mother's nursing home is one of 140 on the state's "Watch List." Families for Better Care, a citizen advocacy organization, found that one in five facilities in Florida are on that list for not meeting state standards, or for not making corrections quickly enough. Twelve of the homes have been on the watch list for more than 100 days. Brian Lee, executive director for Families for Better Care, says that is unacceptable.

Treatment for ADHD: Is more complex treatment cost-effective for more complex cases?

A combination of medication and behavioral therapy is the most cost-effective treatment for children with attention problems complicated by other mental health issues such as depression, anxiety or aggression, according to a new analysis.

Read more Medical News

› Verified 1 days ago